spacer
spacer

PDBsum entry 3d25

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Immune system PDB id
3d25

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
274 a.a. *
98 a.a. *
Ligands
VAL-LEU-HIS-ASP-
ASP-LEU-LEU-GLU-
ALA
Waters ×354
* Residue conservation analysis
PDB id:
3d25
Name: Immune system
Title: Crystal structure of ha-1 minor histocompatibility antigen bound to human class i mhc hla-a2
Structure: Hla class i histocompatibility antigen, a-2 alpha chain. Chain: a. Synonym: mhc class i antigen a 2. Engineered: yes. Beta-2-microglobulin. Chain: b. Fragment: unp residues 22-119. Synonym: beta-2-microglobulin form pi 5.3. Engineered: yes.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: hla-a, hlaa. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: b2m, cdabp0092, hdcma22p. Synthetic: yes. Other_details: the peptide is commercially synthesized. It is found
Resolution:
1.30Å     R-factor:   0.169     R-free:   0.204
Authors: S.Nicholls,K.P.Piper,F.Mohammed,T.R.Dafforn,S.Tenzer,M.Salim, P.Mahendra,C.Craddock,P.Van Endert,H.Schild,M.Cobbold,V.H.Engelhard, P.A.H.Moss,B.E.Willcox
Key ref:
S.Nicholls et al. (2009). Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition. Proc Natl Acad Sci U S A, 106, 3889-3894. PubMed id: 19234124 DOI: 10.1073/pnas.0900411106
Date:
07-May-08     Release date:   10-Feb-09    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P04439  (1A03_HUMAN) -  HLA class I histocompatibility antigen, A alpha chain from Homo sapiens
Seq:
Struc:
365 a.a.
274 a.a.*
Protein chain
Pfam   ArchSchema ?
P61769  (B2MG_HUMAN) -  Beta-2-microglobulin from Homo sapiens
Seq:
Struc:
119 a.a.
98 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 19 residue positions (black crosses)

 

 
DOI no: 10.1073/pnas.0900411106 Proc Natl Acad Sci U S A 106:3889-3894 (2009)
PubMed id: 19234124  
 
 
Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.
S.Nicholls, K.P.Piper, F.Mohammed, T.R.Dafforn, S.Tenzer, M.Salim, P.Mahendra, C.Craddock, P.van Endert, H.Schild, M.Cobbold, V.H.Engelhard, P.A.Moss, B.E.Willcox.
 
  ABSTRACT  
 
T cell recognition of minor histocompatibility antigens (mHags) underlies allogeneic immune responses that mediate graft-versus-host disease and the graft-versus-leukemia effect following stem cell transplantation. Many mHags derive from single amino acid polymorphisms in MHC-restricted epitopes, but our understanding of the molecular mechanisms governing mHag immunogenicity and recognition is incomplete. Here we examined antigenic presentation and T-cell recognition of HA-1, a prototypic autosomal mHag derived from single nucleotide dimorphism (HA-1(H) versus HA-1(R)) in the HMHA1 gene. The HA-1(H) peptide is restricted by HLA-A2 and is immunogenic in HA-1(R/R) into HA-1(H) transplants, while HA-1(R) has been suggested to be a "null allele" in terms of T cell reactivity. We found that proteasomal cleavage and TAP transport of the 2 peptides is similar and that both variants can bind to MHC. However, the His>Arg change substantially decreases the stability and affinity of HLA-A2 association, consistent with the reduced immunogenicity of the HA-1(R) variant. To understand these findings, we determined the structure of an HLA-A2-HA-1(H) complex to 1.3A resolution. Whereas His-3 is accommodated comfortably in the D pocket, incorporation of the lengthy Arg-3 is predicted to require local conformational changes. Moreover, a soluble TCR generated from HA-1(H)-specific T-cells bound HA-1(H) peptide with moderate affinity but failed to bind HA-1(R), indicating complete discrimination of HA-1 variants at the level of TCR/MHC interaction. Our results define the molecular mechanisms governing immunogenicity of HA-1, and highlight how single amino acid polymorphisms in mHags can critically affect both MHC association and TCR recognition.
 
  Selected figure(s)  
 
Figure 3.
Crystallographic structure of HLA-A2-VLH at 1.3Å. (A) Overall structure of HLA-A2-VLH complex, with heavy chain (gray), β2m (cyan), and VLH peptide (blue) shown. (B) 2Fo-Fc electron density for the VLH peptide, with primary anchors and P3 to P5 highlighted. (C) Structure of the VLH mHag in the HLA-A2-antigen binding groove, with antigen-binding pockets A to F indicated, and VLH peptide surface indicated in green. The structure highlights relatively poor contacts with pockets E and F. (D) Orientation of H3 in and around the D pocket. H3 packs snugly against the walls of the D pocket, maintaining van der Waal's contacts with Tyr-159, Leu-156, and Gln-155, and also to Asp-4 of the peptide. It is also participates in a hydrogen-bonding network to Gln-155, and peptide residues Asp-4 and Asp-5, via ordered water molecules. Semitransparent peptide surface shown in green.
Figure 4.
Surface plasmon resonance analysis of TCR/HLA-A2-HA-1 interaction. (A) Specific binding of KP7 TCR to HLA-A2-VLH (solid line), with control (HLA-B7-TPR) and HLA-A2-VLR signals also shown (dashed and dotted lines, respectively). (B) Equilibrium affinity analysis of TCR/HLA-A2-VLH interaction. Scatchard plot is shown inset.
 
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
  21301477 M.Bleakley, and S.R.Riddell (2011).
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.
  Immunol Cell Biol, 89, 396-407.  
20160060 Y.Ofran, H.T.Kim, V.Brusic, L.Blake, M.Mandrell, C.J.Wu, S.Sarantopoulos, R.Bellucci, D.B.Keskin, R.J.Soiffer, J.H.Antin, and J.Ritz (2010).
Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
  Clin Cancer Res, 16, 1642-1651.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer